ASCO 2016 Preconference Report

13 May 2016

The preconference report is the ultimate guide for everyone planning to attend, and everyone interested in, the American Society of Clinical Oncology (ASCO) 2016 meeting. It highlights 34 key abstracts across 18 indications as highly important. Alongside the key abstracts are 24 BioPharm Insight articles based on interviews with Key Opinion Leaders.

Read the report to get forward-looking analyses on checkpoint inhibitors, other immune-oncology treatments, targeted therapies and hematological cancer drugs that will be showcased at ASCO.